<SEC-DOCUMENT>0001169245-22-000037-index.html : 20220422
<SEC-HEADER>0001169245-22-000037.hdr.sgml : 20220422
<ACCEPTANCE-DATETIME>20220422161354
ACCESSION NUMBER:		0001169245-22-000037
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20220422
FILED AS OF DATE:		20220422
DATE AS OF CHANGE:		20220422

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PhaseBio Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001169245
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				030375697
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38697
		FILM NUMBER:		22845669

	BUSINESS ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		(610) 981-6500

	MAIL ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Phase Biosciences Inc
		DATE OF NAME CHANGE:	20061013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DT BIOSCIENCES INC
		DATE OF NAME CHANGE:	20020315
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>proxy2022.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: proxy2022.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>phasebio2020logoa.jpg
<TEXT>
Document 2 - file: phasebio2020logoa.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>phasebio2020proxystat_imaga.gif
<TEXT>
Document 3 - file: phasebio2020proxystat_imaga.gif

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>proxycardpg1a.jpg
<TEXT>
Document 4 - file: proxycardpg1a.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>proxycardpg2a.jpg
<TEXT>
Document 5 - file: proxycardpg2a.jpg

</DOCUMENT>
</SEC-DOCUMENT>